HOME › DRUGS › PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED)
ACTIVE SUBSTANCE / INN

PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED)

Brand name(s): Synflorix, Vaxneuvance
EMA LISTED
AUTHORISED
Pneumococcal Infections;Immunization
Pneumococcal Infections
ACTIVE SUBSTANCE
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
REGULATORS
EMA
SPONSORS / MAH
Merck Sharp & Dohme B.V. , GlaxoSmithKline Biologicals S.A.
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VaxneuvanceMerck Sharp & Dohme B.V. Authorised13/12/2021Pneumococcal Infections
SynflorixGlaxoSmithKline Biologicals S.A.Authorised29/03/2009Pneumococcal Infections;Immunization

FULL INTELLIGENCE ON PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →